Effect and mechanism of berberine in alleviating contrast-induced nephropathy through regulating protein kinase B

Objective To explore the inhibitory effect of berberine （BBR） on contrast-induced nephropathy （CIN） and clarify the underlying mechanism. Methods Sprague-Dawley （SD） rats were utilized for constructing a rat CIN model. BBR treatment group （M+B） received a gavage of 200 mg/kg BBR while control group...

Full description

Bibliographic Details
Published in:	Linchuang shenzangbing zazhi
Main Authors:	Ran Yu, Yao Xiao, Wan-peng Wang, Qing-ju Li, Hao-yu Chen, Jian Song, Jia-jia Chen
Format:	Article
Language:	Chinese
Published:	Editorial Department of Journal of Clinical Nephrology 2024-10-01
Subjects:	contrast induced nephropathy berberine protein kinase b apoptosis
Online Access:	http://www.lcszb.com/cn/article/doi/10.3969/j.issn.1671-2390.2024.10.008

Similar Items

Inhibitory Effects of Isoquinoline Alkaloid Berberine on Ischemia-Induced Apoptosis via Activation of Phosphoinositide 3-Kinase/Protein Kinase B Signaling Pathway
by: Mia Kim, et al.
Published: (2014-09-01)

Effect of Astragalus injection on neutrophil gelatinase associated lipocalin level in patients with contrast-induced nephropathy
by: XIAO Yong-jia, et al.
Published: (2019-01-01)

Effective long-term hemofiltration in contrast-induced nephropathy
by: E. A. Tabakyan, et al.
Published: (2010-10-01)

Contrast-induced nephropathy: a review of literature
by: Roya Narenji Sani, et al.
Published: (2015-10-01)

Contrast-induced nephropathy; A literature review
by: Jafar Golshahi, et al.
Published: (2014-04-01)

Contrast-induced nephropathy: a review of literature
by: Roya Narenji Sani, et al.
Published: (2015-09-01)

Protective effects of hydroxytyrosol on contrast-induced nephropathy in rats
by: PAN Pei-qiang, et al.
Published: (2019-01-01)

Risk factors of contrast-induced nephropathy after coronary angiography and the countermeasures
by: YANG Shu-mei, et al.
Published: (2016-01-01)

Experimental rat models for contrast-induced nephropathy; a comprehensive review
by: Marlon Perera, et al.
Published: (2020-04-01)

Contrast induced nephropathy in women with infertility undergoing hysterosalpingography
by: Akin Usta, et al.
Published: (2024-12-01)

Contrast-induced nephropathy (CIN) - epidemiology, risk factors and prevention
by: Jakub Rafał Pierzchała, et al.
Published: (2022-10-01)

CONTRAST-INDUCED NEPHROPATHY IN CARDIOLOGY PRACTICE
by: O. I. Turenko, et al.
Published: (2011-06-01)

Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
by: Peyman Bidram, et al.
Published: (2015-01-01)

Diagnostic value of serum Cystatin C for contrast-induced nephropathy:A Meta-analysis
by: WANG Yu-qin, et al.
Published: (2016-01-01)

Ethanol extract of Abelmoschus manihot suppresses endoplasmic reticulum stress in contrast-induced nephropathy
by: Xin Lin, et al.
Published: (2024-01-01)

Contrast-induced nephropathy - prevention and treatment
by: Mateusz Bajak, et al.
Published: (2024-11-01)

Risk Factors For Contrast Induced Nephropathy in Surgical Intensive Care Unit Patients
by: Coşkun Araz, et al.
Published: (2012-04-01)

Different routes of N-acetylcysteineon administration in preventing contrast-induced nephropathy in mild renal impairment patients undergoing contrast-enhanced CT
by: XU Xiao, et al.
Published: (2015-01-01)

Personalized contrast agent dosing to prevent contrast induced nephropathy in high risk populations in Guangdong, China
by: Minqi Liao, et al.
Published: (2025-02-01)

Does metabolic syndrome increase contrast-induced nephropathy in patients with normal renal function?
by: Hasan Shemirani, et al.
Published: (2024-01-01)

The prevention of sodium bicarbonate hydration therapy with contrast-induced nephropathy
by: TANG Na, et al.
Published: (2015-01-01)

A risk prediction model for contrast-induced nephropathy associated with gadolinium-based contrast agents
by: Huanhuan Zheng, et al.
Published: (2022-12-01)

The Impact of Hydration and Other Strategies in prevention of Contrast-Induced Nephropathy
by: Joanna Wojtania, et al.
Published: (2024-07-01)

Tacrolimus repairs glomerular podocytes injury in rats with adriamycin induced nephropathy
by: CHEN Cai-ming, et al.
Published: (2020-01-01)

The Incidence and Associated Risk Factors of Contrast-Induced Nephropathy after Contrast-Enhanced Computed Tomography in the Emergency Setting: A Systematic Review
by: Mei-Yi Ong, et al.
Published: (2022-06-01)

Impact of high dose versus low dose atorvastatin on contrast induced nephropathy in diabetic patients with acute coronary syndrome undergoing early percutaneous coronary intervention
by: Haitham Galal, et al.
Published: (2015-12-01)

Meta-analysis of alprostadil E1 on prevention of contrast-induced nephropathy
by: JIAN Yong-hong, et al.
Published: (2015-01-01)

Application of disease prediction model in chronic kidney disease complicated with contrast induced nephropathy
by: ZHOU Min, et al.
Published: (2019-01-01)

Effect and mechanism of heparin on iodine contrast nephropathy: A bibliometric analysis
by: Wei Huang, et al.
Published: (2025-07-01)

Contrast-induced nephropathy in invasive cardiology
by: Tilman N.U. Perrin, et al.
Published: (2012-06-01)

Atorvastatin attenuates contrast-induced nephropathy by modulating inflammatory responses through the regulation of JNK/p38/Hsp27 expression
by: Xuyu He, et al.
Published: (2016-05-01)

Endogenous and Exogenous Antioxidants as Agents Preventing the Negative Effects of Contrast Media (Contrast-Induced Nephropathy)
by: Ina G. Panova, et al.
Published: (2023-07-01)

Contrast-Induced Nephropathy: An Overview
by: Yuvashri Kaliyaperumal, et al.
Published: (2023-10-01)

Contrast media induced nephropathy: case series and review of the literature focusing on management
by: Putu Agus Marciyasa, et al.
Published: (2024-08-01)

Acute Kidney Injury After Primary Angioplasty: Is Contrast‐Induced Nephropathy the Culprit?
by: Oren Caspi, et al.
Published: (2017-11-01)

Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches
by: Prit Kusirisin, et al.
Published: (2020-10-01)

Effect of omega-3 fatty acid on contrast-induced nephropathy
by: Gunes Bolatli, et al.
Published: (2021-09-01)

Evaluating the role of trimetazidine in preventing myocardial injury and contrast-induced nephropathy in patients undergoing percutaneous coronary interventions
by: Anshul Jain, et al.
Published: (2025-05-01)

“CONTRAST” STUDY: COMPARİSİON OF NEPHROPROTECTİVE THREE PROTOCOLS: ACETYLCYSTEİNESODİUM BİCARBONATE-THEOPHYLLİNE, TO PREVENT CONTRAST-İNDUCED NEPHROPATHY
by: Ilker Murat Caglar, et al.
Published: (2014-01-01)

Microalbuminuria predicts contrast-induced nephropathy in patients with acute coronary syndrome
by: Yevgeniy Korolov, et al.
Published: (2021-02-01)